These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17300133)

  • 1. Monitoring statin safety in primary care.
    Tragni E; Filippi A; Mazzaglia G; Sessa E; Cricelli C; Catapano AL
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):652-7. PubMed ID: 17300133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization.
    Charles EC; Olson KL; Sandhoff BG; McClure DL; Merenich JA
    Am J Med; 2005 Jun; 118(6):618-24. PubMed ID: 15922693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining frequency of liver enzyme abnormalities with statins: experience from general practice in Jerusalem.
    Kiderman A; Ben-Dov IZ; Glikberg F; Ackerman Z
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1002-5. PubMed ID: 18787468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
    Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
    Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.
    Petrella RJ; Merikle E; Jones J
    Clin Ther; 2007 Apr; 29(4):742-50. PubMed ID: 17617298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Special recommendations for lipid-lowering treatment: efficacy and safety].
    Martinez TL; Nascimento HM
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():6-8. PubMed ID: 16400389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.
    García-Rodríguez LA; González-Pérez A; Stang MR; Wallander MA; Johansson S
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):953-61. PubMed ID: 18425987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and cancer risk.
    Karp I; Behlouli H; Lelorier J; Pilote L
    Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice.
    Kim H; Lee H; Kim TM; Yang SJ; Baik SY; Lee SH; Cho JH; Lee H; Yim HW; Choi IY; Yoon KH; Kim HS
    Cardiovasc Ther; 2018 Jun; 36(3):e12324. PubMed ID: 29464863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of statins on the liver: clinical analysis of patients with ischemic stroke.
    Zhang LS; Liu ZX; Lü W; Hu XY
    Chin Med J (Engl); 2011 Mar; 124(6):897-900. PubMed ID: 21518599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation of statin treatment and all-cause mortality: a population-based cohort study.
    Shalev V; Chodick G; Silber H; Kokia E; Jan J; Heymann AD
    Arch Intern Med; 2009 Feb; 169(3):260-8. PubMed ID: 19204217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance to recommended liver function monitoring in patients on statin therapy.
    Leaver H; Keng Lim T; Thomson P; Leaver J; Choy AM; Lang CC
    Cardiovasc Ther; 2009; 27(2):96-100. PubMed ID: 19426246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea.
    Kim HS; Lee SH; Kim H; Lee SH; Cho JH; Lee H; Yim HW; Kim SH; Choi IY; Yoon KH; Kim JH
    J Clin Pharm Ther; 2016 Jun; 41(3):266-72. PubMed ID: 27015878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors related to adherence to statin therapy.
    McGinnis B; Olson KL; Magid D; Bayliss E; Korner EJ; Brand DW; Steiner JF
    Ann Pharmacother; 2007 Nov; 41(11):1805-11. PubMed ID: 17925498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.
    McClure DL; Valuck RJ; Glanz M; Murphy JR; Hokanson JE
    J Clin Epidemiol; 2007 Aug; 60(8):812-8. PubMed ID: 17606177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival.
    Leeper NJ; Ardehali R; deGoma EM; Heidenreich PA
    Circulation; 2007 Aug; 116(6):613-8. PubMed ID: 17664373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.